MIRABILE, AURORA

MIRABILE, AURORA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 16 di 16 (tempo di esecuzione: 0.003 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis : a randomized, double-blind study 1-gen-2015 L. LicitraA. MirabileS. FavaA.L. Ciuffreda + Article (author) -
Comment on "acute toxicity of three versus two courses of cisplatin for radiochemotherapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN) : A matched pair analysis", by Rades et coll 1-dic-2010 A. MirabileL. Licitra + Article (author) -
A ct-based radiomic signature can be prognostic for 10-months overall survival in metastatic tumors treated with nivolumab : An exploratory study 28-mag-2021 Licitra L.Mirabile A. + Article (author) -
Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer 11-mar-2011 A. MirabileL. Licitra + Article (author) -
Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer 1-gen-2014 A. MirabileC. ResteghiniL. Licitra + Article (author) -
Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy 1-apr-2016 A. MirabileC. ResteghiniE. ConteL. Licitra + Article (author) -
Italian version of the M.D. Anderson Symptom Inventory - €”Head and Neck Module : linguistic validation 1-gen-2015 A. MirabileD. MonzaniL. Licitra + Article (author) -
MALT lymphoma and Kaposi Sarcoma in an HIV-negative patient 1-ott-2010 A. MirabileA. Gianni + Article (author) -
Pain management in head and neck cancer patients undergoing chemo-radiotherapy : Clinical practical recommendations 1-mar-2016 A. MirabileL. Licitra + Article (author) -
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas : Translational analyses and clinical impact 1-dic-2016 F. PerroneC. ResteghiniA. MirabileSAIBENE, GIORGIOL. Licitra + Article (author) -
Predictors of Patient-Reported Dysphagia Following IMRT Plus Chemotherapy in Oropharyngeal Cancer 1-feb-2019 Infante, GabrieleMirabile, AuroraSchindler, AntonioPizzorni, NicoleLicitra, LisaBossi, Paolo + Article (author) -
Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck 16-gen-2019 Mirabile, AuroraCalderone, Rosa GioiaMariani, LuigiLicitra, Lisa + Article (author) -
Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients 26-mag-2021 Corino V.Mirabile A.Mainardi L.Licitra L. F. + Article (author) -
Sepsis in head and neck cancer patients treated with chemotherapy and radiation : literature review and consensus 1-gen-2015 A. MirabileL. Licitra + Article (author) -
Targeted therapy in head and neck cancer 1-gen-2011 L. LicitraA. Mirabile + Article (author) -
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer : An Italian validation study 1-lug-2012 F. PerroneA. MirabileL. Licitra + Article (author) -